Category: Prematurity
Poster Session IV
To determine differences in latency from preterm rupture of membranes (PPROM) to delivery, chorioamnionitis and neonatal sepsis in pregnancies by cerclage removal (CR) timing.
Study Design:
Retrospective cohort study of singleton pregnancies managed with cerclage for history, ultrasound or physical exam indications between June 2016-August 2020 at 10 sites across the United States and Colombia. Exposure of interest was timing from PPROM to CR (immediate, delayed for 48 hours (h) and delayed > 48 h). Primary outcome of interest was latency from PPROM to delivery. Secondary outcomes included chorioamnionitis and neonatal sepsis. Statistical analysis included bivariate and multivariate techniques.
Results:
Of 842 pregnancies managed with cerclage, 165 (19.2%) experienced PPROM with cerclage in place. 48 records were excluded due to missing data on gestational age (GA) at CR and/or at time of PPROM. 117 records were included in final analysis. Over half of patients underwent immediate CR (54.7%, n=64), 17.1% delayed but removed within 48 h (n=20) and 28.2% delayed CR > 48 h (n=33). Median delivery GA was similar between groups (26.0 wks [IQR 21.5-30.0] immediate, 27.5 wks [IQR 24.0-30.5] within 48 h, 28.0 wks [IQR 25.0-29.0] > 48 h group; p=0.45). In linear regression, there was a statistically significant relationship between days from PPROM to CR and latency to delivery (p < 0.0001). Number of days from PPROM to CR accounted for 79.8% of explained variability of latency to delivery. Each additional day with cerclage in place was associated with average 0.82 days of latency. When comparing immediate vs. delayed CR (CR within 48 h or > 48 h as one group), histologic chorioamnionitis was higher in pregnancies with delayed CR (58.5% delayed vs. immediate CR 38.7%; p=0.03) and neonatal sepsis was similar between groups (7.3% delayed vs.13.9% immediate CR; p=0.46).
Conclusion:
Delayed cerclage removal after PPROM was associated with increased latency from PPROM to delivery but also with increased histologic chorioamnionitis. Further safety data are needed before recommending cerclage retention after PPROM.
Joanne N. Quiñones, MD, MSCE (she/her/ella)
Vice Chair, Research, Department of Obstetrics & Gynecology
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Rupsa C. Boelig, MD, MS
Assistant Professor
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Shirin Azadi, MD
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Onyinyech Anosike, DO
Resident Physician
Department of Obstetrics and Gynecology, Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Eshika Agarwal, BS
Medical Student
Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania
Lawrenceville, New Jersey, United States
Leah Ledford Carnick, MSN
Atrium Health Women's Institute
Charlotte, North Carolina, United States
Maria T. Martinez-Baladejo, MD
Department of Research & Innovation, St. Luke's University Health Network, Bethlehem, Pennsylvania
Bethlehem, Pennsylvania, United States
Arturo Cardona, MD
Departamento de Obstetricia y Ginecología, Medicina Materno-Fetal, Clínica del Prado
Medellin, Colombia, Colombia
Monica Rincon, MD, MSCR
Coordinator MFM Research
Department of Obstetrics and Gynecology, Oregon Health and Science University
Portland, Oregon, United States
Richard Burwick, MD, MPH
San Gabriel Valley Perinatal Medical Group
West Covina, California, United States
Luisa Lopez-Torres, MD, MPH
Fellow Medicina Materno Fetal
Departamento de Obstetricia y Ginecología, Medicina Materno Fetal, Universidad Pontificia Bolivariana, Medellín, Colombia
Medellin, Antioquia, Colombia
Catalina Maria M. Valencia, MD
Especialista, Co-Directora
Medicina Fetal SAS
Medellin, Antioquia, Colombia
Jorge E. Tolosa, MD, MSCE (he/him/his)
Professor in Obstetrics & Gynecology
St Luke's University Health Network
Bethlehem, Pennsylvania, United States